India reports 8,603 fresh COVID-19 infections, toll climbs to 4,70,530 with 415 fatalities
The active coronavirus caseload declined to 99,974, comprising 0.29 percent of the total infections, the lowest since March 2020
New Delhi: With 8,603 people testing positive for coronavirus infection in a day, India's tally of COVID-19 cases rose to 3,46,24,360, but active cases declined to 99,974, according to Union Health Ministry data updated on Saturday.
The death toll, however, climbed to 4,70,530 with 415 fatalities reported on Saturday, the data released at 8 am showed.
The daily rise in coronavirus infections has been less than 50,000 for 160 consecutive days now.
The active cases have declined to 99,974, comprising 0.29 percent of the total infections, the lowest since March 2020, while the national COVID-19 recovery rate was recorded at 98.35 percent, the health ministry said.
A net decrease of two cases has been recorded in the active COVID-19 caseload in a span of 24 hours, according to the ministry.
The daily positivity rate was recorded at 0.69 percent. It has been less than 2 percent for past 61 days now.
The weekly positivity rate was also recorded at 0.81 percent. It has been below 1 percent for the past 20 days, the ministry data showed.
The number of people who have recuperated from the disease rose to 3,40,53,856 while the case fatality rate was recorded at 1.36 percent.
The cumulative number of COVID-19 vaccine doses administered in the country so far under the nationwide drive has exceeded 126.53 crore.
If the West has long expertise in propaganda, we do have a longer memory that has not yet been fully extinguished. We need investment in the sparking of that memory to life, to global life. Without such an investment, we won’t have a ‘Jagat Guru’ role to play in the world
Djokovic won a court battle Monday to stay in Australia despite not being vaccinated against COVID-19, but the drama might not be finished, with the government threatening to cancel his visa a second time and deport him.
The clinical trial found that both groups showed increases in antibodies slightly higher than following the third vaccine last year. But it said the increased antibodies did not prevent the spread of omicron